Midazolam

MELT-300 demonstrated in a pivotal phase 3 study positive topline results in IV- and opioid-free procedural sedation for patients undergoing cataract surgery, according to a press release from Melt Pharmaceuticals.

Rafa Laboratories announced the FDA has granted approval for its 10 mg midazolam autoinjector to treat status epilepticus in adults.

Ketamine improved neurocognitive outcomes at 24 hours among patients with depression and suicidal ideation, according to study results published in Journal of Clinical Psychiatry.

In this OSN Video Perspective from the virtual OSN New York meeting, John P. Berdahl, MD, discusses his experience with as well as the latest science around use of the MKO Melt in cataract surgery.

Personalized music may be a viable option for reducing perioperative anxiety in patients undergoing Mohs micrographic surgery, but more data are needed to determine its effects, according to a systematic review.